Clinical Trial Update: A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating capecitabine, trastuzumab, and oxaliplatin in patients with resectable gastric cancer has completed, with results posted in Oc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• HERCEPTIN (trastuzumab)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-10-01